Deciphera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Deciphera Pharmaceuticals

04/05/2022 19:45

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 80 cents​​ per share for the quarter ended in
March. The mean expectation of eleven analysts for the quarter
was for a loss of 90 cents per share.
    * Revenue rose 16.2% to $29.22 million from a year ago; 
analysts
expected $26.43 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 80 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Deciphera Pharmaceuticals Inc shares had risen by 13.8%
this
quarter and gained 8.0% so far this year.
    * The company reported a quarterly loss of $46.89 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $11.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated May 4 at 06:45 p.m.  ​All
figures in US dollars unless otherwise stated